SCHEMBL3162235

SCHEMBL3162235

CC(=O)NCCNc1cc(NC(=O)CN2CCN(C(c3ccccc3)c3ccccc3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ HTT P42858 2/20 0.45
▸ CA1 P00915 2/20 0.45
▸ CA2 P00918 2/20 0.45
▸ CA7 P43166 2/20 0.45
▸ LMNA P02545 2/20 0.45
▸ GAA P10253 1/20 0.45
▸ POLB P06746 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ RECQL P46063 1/20 0.44
▸ CA9 Q16790 1/20 0.42
▸ DRD2 P14416 2/20 0.41
▸ DRD3 P35462 2/20 0.41
▸ ADORA3 P0DMS8 5/20 0.41
▸ ADORA2A P29274 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3172420 0.95 DRD2 (0.46) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL3169342 0.94 CA1 (0.45) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL3171920 0.88 ADORA1 (0.47) KDM4EALDH1A1ADORA3ADORA2AADORA1
SCHEMBL3163144 0.87 ADORA3 (0.46) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL3163125 0.87 NPC1 (0.47) KDM4EALDH1A1MEN1KMT2ANPSR1
SCHEMBL3164709 0.87 NPC1 (0.47) KDM4EALDH1A1MEN1KMT2ANPSR1
SCHEMBL3162425 0.86 EGFR (0.53) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL3163746 0.86 ALDH1A1 (0.50) SMN1; SMN2ALDH1A1MEN1KMT2ANPSR1
SCHEMBL3169937 0.86 ALDH1A1 (0.48) ALDH1A1ADORA3ADORA2AADORA1ADORA2B
SCHEMBL3164858 0.85 ALDH1A1 (0.49) SMN1; SMN2KDM4EALDH1A1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback